Live Breaking News & Updates on Revelation biosciences company profile

Stay informed with the latest breaking news from Revelation biosciences company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Revelation biosciences company profile and stay connected to the pulse of your community

Revelation Biosciences, Inc. (NASDAQ:REVB) Forecasted to Post Q1 2024 Earnings of ($1.77) Per Share

Revelation Biosciences, Inc. (NASDAQ:REVB) Forecasted to Post Q1 2024 Earnings of ($1.77) Per Share
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Revelation-biosciences-inc , Nasdaq , Sabby-management , Revelation-biosciences-company-profile , Revelation-biosciences , Free-report , Roth-capital , Revelation-bioscience , Street-corp , Funds-management , Get-free-report

Revelation Biosciences, Inc. (NASDAQ:REVBW) Sees Large Growth in Short Interest

Revelation Biosciences, Inc. (NASDAQ:REVBW – Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 29th, there was short interest totalling 9,300 shares, an increase of 244.4% from the February 14th total of 2,700 shares. Based on an average daily trading volume, of 67,100 […]

Nasdaq , Revelation-biosciences-inc , Revelation-biosciences-company-profile , Revelation-biosciences , Get-free-report , Revelation-biosciences-daily ,

Revelation Biosciences (NASDAQ:REVB) Shares Down 1.3%

Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report)’s share price dropped 1.3% on Thursday . The stock traded as low as $0.41 and last traded at $0.43. Approximately 16,415 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 63,276 shares. The stock had previously closed at $0.44. Revelation […]

Revelation-biosciences-inc , Walleye-capital , Revelation-biosciences-company-profile , Sabby-management , Virtu-financial , Nasdaq , Revelation-biosciences , Get-free-report , Bay-capital-management , Revelation-biosciences-daily , Nasdaq-revb

Revelation Biosciences (NASDAQ:REVB) Shares Down 5.5%

Shares of Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) were down 5.5% during mid-day trading on Monday . The stock traded as low as $0.59 and last traded at $0.60. Approximately 20,590 shares traded hands during trading, a decline of 94% from the average daily volume of 322,707 shares. The stock had previously closed […]

Sabby-management , Revelation-biosciences-inc , Revelation-biosciences-company-profile , Nasdaq , Walleye-capital , Revelation-biosciences , Get-free-report , Biosciences-trading-down , Capital-management , Funds-management , Hudson-bay-capital-management

Revelation Biosciences (NASDAQ:REVB) Issues Quarterly Earnings Results, Beats Expectations By $0.08 EPS

Revelation Biosciences (NASDAQ:REVB – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.33) by $0.08, reports. Revelation Biosciences Stock Up 0.3 % REVB stock traded up $0.00 during midday trading on Monday, hitting $0.75. The company’s stock had […]

Virtu-financial , Revelation-biosciences-company-profile , Sabby-management , Revelation-biosciences-inc , Revelation-biosciences , Get-free-report , Funds-management , Bay-capital-management , Street-corp , Revelation-biosciences-daily , Nasdaq-revb

Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW – Get Free Report) was the recipient of a significant decrease in short interest in July. As of July 15th, there was short interest totalling 10,800 shares, a decrease of 23.4% from the June 30th total of 14,100 shares. Based on an average daily trading volume, of 34,100 shares, the short-interest […]

Nasdaq , Revelation-biosciences-company-profile , Revelation-biosciences-inc , Revelation-biosciences , Get-free-report , Revelation-biosciences-daily , Nasdaq-revbw , Revbw , Medical , Stocks , Options

Short Interest in Revelation Biosciences, Inc. (NASDAQ:REVB) Decreases By 39.8%

Revelation Biosciences, Inc. (NASDAQ:REVB – Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 57,000 shares, a decline of 39.8% from the May 31st total of 94,700 shares. Based on an average daily volume of 668,300 shares, the […]

Georgef-tidmarsh , Securities-exchange-commission , Nasdaq , Revelation-biosciences-company-profile , Revelation-biosciences-inc , Revelation-biosciences , Free-report , Director-george , Exchange-commission , Capital-management , Street-corp

Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW – Free Report) saw a significant drop in short interest in June. As of June 15th, there was short interest totalling 11,700 shares, a drop of 52.8% from the May 31st total of 24,800 shares. Based on an average daily volume of 56,800 shares, the days-to-cover ratio is presently 0.2 days. […]

Revelation-biosciences-company-profile , Revelation-biosciences-inc , Nasdaq , Revelation-biosciences , Free-report , Revelation-biosciences-daily ,

Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW – Free Report) saw a large decline in short interest in June. As of June 15th, there was short interest totalling 11,700 shares, a decline of 52.8% from the May 31st total of 24,800 shares. Based on an average daily trading volume, of 56,800 shares, the days-to-cover ratio is presently 0.2 […]

Revelation-biosciences-inc , Revelation-biosciences-company-profile , Nasdaq , Revelation-biosciences , Free-report , Revelation-biosciences-daily , Nasdaq-revbw , Revbw , Medical , Stocks , Options

Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW – Free Report) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 11,700 shares, a drop of 52.8% from the May 31st total of 24,800 shares. Based on an average trading volume of 56,800 shares, the […]

Revelation-biosciences-inc , Nasdaq , Revelation-biosciences-company-profile , Revelation-biosciences , Free-report , Biosciences-trading-down , Revelation-biosciences-daily ,